article thumbnail

HRS 2024: Innovation Meets Reality

DAIC

Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results. So, again, innovation is great.

article thumbnail

Heart Rhythm Society’s HRX 2024 to Draw Cardiovascular Innovators to Atlanta

DAIC

The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept. On Thursday, Sept.

article thumbnail

SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement

DAIC

milla1cf Mon, 03/18/2024 - 07:30 March 18, 2024 — SS Innovations International, Inc. , Dr. Srivastava said: “SS Innovations is dedicated to improving patient access and optimizing surgical outcomes with our accessible and cost-effective surgical robotic system. The mitral valve disease market size was valued at $2.5 from 2022 to 2031.

article thumbnail

New Cassling Team to Drive Growth and Innovation in Healthcare

Cassling

The business unit, Growth & Innovation, is tasked with bringing new services and solutions to market to help healthcare organizations solve their imaging pain points, remain viable and keep providers local.

article thumbnail

Innovative Health Reports Strong Growth in Cost and Environmental Savings for EP Labs at the 2024 Heart Rhythm Society Conference

DAIC

milla1cf Mon, 05/13/2024 - 11:08 May 13, 2024 — Innovative Health , Inc.announced that recent growth in single-use device reprocessing has delivered significant financial and environmental benefits to U.S. HRS attendees can visit Innovative Health at booth No. electrophysiology labs.

article thumbnail

Access to Innovative Drugs Increases Through Biosimilars Adoption

HCPLive

During a 10-year period, estimated access to drugs increased among Polish patients with rheumatic and musculoskeletal diseases.

article thumbnail

Innovative Hemophilia Treatments Offer Hope Amid Lingering Clinical Challenges

HCPLive

At ASH 2024, Annette von Drygalski, MD, PharmD, described the paradigm shift that has taken place in hemophilia over the past decade.